Skip to main content
SpringerLink
Log in

Melanocytic Proliferations and Other Pigmented Lesions

  • Chapter
  • First Online:
Pediatric Dermatopathology

  • 1657 Accesses

Abstract

This chapter reviews pigmented skin lesions of varied etiology. Some are acquired while others are present at birth or inherited as part of a genetic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fulk CS. Primary disorders of hyperpigmentation. J Am Acad Dermatol. 1984;10(1):1–16.

    Article  CAS  PubMed  Google Scholar 

  2. Hafner C, Stoehr R, van Oers JM, Zwarthoff EC, Hofstaedter F, Klein C, Landthaler M, Hartmann A, Vogt T. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo. J Invest Dermatol. 2009;129(11):2730–5.

    Article  CAS  PubMed  Google Scholar 

  3. Cramer SF. The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol 1984;6 Suppl: 289–98

    Google Scholar 

  4. Vierkotter A, Kramer U, Sugiri D, Morita A, Yamamoto A, Kaneko N, Matsui M, Krutmann J. Development of lentigines in German and Japanese women correlates with variants in the SLC45A2 gene. J Invest Dermatol. 2011;132(3 Pt 1):733–6.

    PubMed  Google Scholar 

  5. Samuelov L, Sarig O, Gat A, Halachmi S, Shalev S, Sprecher E. Extensive lentigo simplex, linear epidermolytic naevus and epidermolytic naevus comedonicus caused by a somatic mutation in KRT10. Br J Dermatol. 2014;173(1):293–6.

    Article  Google Scholar 

  6. Pais S, Hegde SK, Bhat SS. Oral melanotic macule--a case report. J Indian Soc Pedod Prev Dent. 2004;22(2):73–5.

    CAS  PubMed  Google Scholar 

  7. Carlos-Bregni R, Contreras E, Netto AC, Mosqueda-Taylor A, Vargas PA, Jorge J, Leon JE, de Almeida OP. Oral melanoacanthoma and oral melanotic macule: a report of 8 cases, review of the literature, and immunohistochemical analysis. Med Oral Patol Oral Cir Bucal. 2007;12(5):E374–9.

    PubMed  Google Scholar 

  8. Spann CR, Owen LG, Hodge SJ. The labial melanotic macule. Arch Dermatol. 1987;123(8):1029–31.

    Article  CAS  PubMed  Google Scholar 

  9. Weathers DR, Corio RL, Crawford BE, Giansanti JS, Page LR. The labial melanotic macule. Oral Surg Oral Med Oral Pathol. 1976;42(2):196–205.

    Article  CAS  PubMed  Google Scholar 

  10. Ho KK, Dervan P, O’Loughlin S, Powell FC. Labial melanotic macule: a clinical, histopathologic, and ultrastructural study. J Am Acad Dermatol. 1993;28(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  11. Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer BJ, Bouwes Bavinck JN. The melanocortin-1-receptor gene is the major freckle gene. Hum Mol Genet. 2001;10(16):1701–8.

    Article  CAS  PubMed  Google Scholar 

  12. Rhodes AR, Albert LS, Barnhill RL, Weinstock MA. Sun-induced freckles in children and young adults. A correlation of clinical and histopathologic features. Cancer. 1991;67(7):1990–2001.

    Article  CAS  PubMed  Google Scholar 

  13. Flanagan N, Healy E, Ray A, Philips S, Todd C, Jackson IJ, Birch-Machin MA, Rees JL. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet. 2000;9(17):2531–7.

    Article  CAS  PubMed  Google Scholar 

  14. Rees J. Genes for freckles. J Invest Dermatol. 2004;123(2):414.

    Article  CAS  PubMed  Google Scholar 

  15. Duffy DL, Montgomery GW, Chen W, Zhao ZZ, Le L, James MR, Hayward NK, Martin NG, Sturm RA. A three-single-nucleotide polymorphism haplotype in intron 1 of OCA2 explains most human eye-color variation. Am J Hum Genet. 2007;80(2):241–52.

    Article  CAS  PubMed  Google Scholar 

  16. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Jakobsdottir M, Steinberg S, Gudjonsson SA, Palsson A, Thorleifsson G, Palsson S, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Vermeulen SH, Goldstein AM, Tucker MA, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet. 2008;40(7):835–7.

    Article  CAS  PubMed  Google Scholar 

  17. Sulem P, Gudbjartsson DF, Stacey SN, Helgason A, Rafnar T, Magnusson KP, Manolescu A, Karason A, Palsson A, Thorleifsson G, Jakobsdottir M, Steinberg S, Palsson S, Jonasson F, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Aben KK, Kiemeney LA, Olafsson JH, Gulcher J, Kong A, Thorsteinsdottir U, Stefansson K. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet. 2007;39(12):1443–52.

    Article  CAS  PubMed  Google Scholar 

  18. Baron AE, Asdigian NL, Gonzalez V, Aalborg J, Terzian T, Stiegmann RA, Torchia EC, Berwick M, Dellavalle RP, Morelli JG, Mokrohisky ST, Crane LA, Box NF. Interactions between ultraviolet light and MC1R and OCA2 variants are determinants of childhood nevus and freckle phenotypes. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2829–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Angelo C, Grosso MG, Stella P, De Sio C, Passarelli F, Puddu P, Paradisi M. Becker’s nevus syndrome. Cutis. 2001;68(2):123–4.

    CAS  PubMed  Google Scholar 

  20. Tate PR, Hodge SJ, Owen LG. A quantitative study of melanocytes in Becker’s nevus. J Cutan Pathol. 1980;7(6):404–9.

    Article  CAS  PubMed  Google Scholar 

  21. Bhawan J, Chang WH. Becker’s melanosis: an ultrastructural study. Dermatologica. 1979;159(3):221–30.

    Article  CAS  PubMed  Google Scholar 

  22. Hsu S, Chen JY, Subrt P. Becker’s melanosis in a woman. J Am Acad Dermatol. 2001;45(6 Suppl):S195–6.

    Article  CAS  PubMed  Google Scholar 

  23. Danarti R, Konig A, Salhi A, Bittar M, Happle R. Becker’s nevus syndrome revisited. J Am Acad Dermatol. 2004;51(6):965–9.

    Article  PubMed  Google Scholar 

  24. Person JR, Longcope C. Becker’s nevus: an androgen-mediated hyperplasia with increased androgen receptors. J Am Acad Dermatol. 1984;10(2 Pt 1):235–8.

    Article  CAS  PubMed  Google Scholar 

  25. Fretzin DF, Whitney D. Familial Becker’s nevus. J Am Acad Dermatol. 1985;12(3):589–90.

    Article  CAS  PubMed  Google Scholar 

  26. Sigg C, Pelloni F, Schnyder UW. Frequency of congenital nevi, nevi spili and cafe-au-lait spots and their relation to nevus count and skin complexion in 939 children. Dermatologica. 1990;180(3):118–23.

    Article  CAS  PubMed  Google Scholar 

  27. Jimbow K, Fitzpatrick TB, Szabo G, Hori Y. Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism. J Invest Dermatol. 1975;64(1):50–62.

    Article  CAS  PubMed  Google Scholar 

  28. Martuza RL, Philippe I, Fitzpatrick TB, Zwaan J, Seki Y, Lederman J. Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study. J Invest Dermatol. 1985;85(4):347–50.

    Article  CAS  PubMed  Google Scholar 

  29. Burwell RG, James NJ, Johnston DI. Cafe-au-lait spots in schoolchildren. Arch Dis Child. 1982;57(8):631–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Benedict PH, Szabo G, Fitzpatrick TB, Sinesi SJ. Melanotic macules in Albright’s syndrome and in neurofibromatosis. JAMA. 1968;205(9):618–26.

    Article  CAS  PubMed  Google Scholar 

  31. Roth JG, Esterly NB. McCune-Albright syndrome with multiple bilateral café au lait spots. Pediatr Dermatol. 1991;8(1):35–9.

    Article  CAS  PubMed  Google Scholar 

  32. Kacerovska D, Nemcova J, Pomahacova R, Michal M, Kazakov DV. Cutaneous and superficial soft tissue lesions associated with Albright hereditary osteodystrophy: clinicopathological and molecular genetic study of 4 cases, including a novel mutation of the GNAS gene. Am J Dermatopathol. 2008;30(5):417–24.

    Article  PubMed  Google Scholar 

  33. Schwartz RA, Spicer MS, Leevy CB, Ticker JB, Lambert WC. Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome. Dermatology. 1996;192(3):258–61.

    Article  CAS  PubMed  Google Scholar 

  34. Aravinda K, Ratnakar P, Srinivas K. Oral manifestations of McCune-Albright syndrome. Indian J Endocrinol Metab. 2013;17(1):170–3.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Davies JH, Barton JS, Gregory JW, Mills C. Infantile McCune-Albright syndrome. Pediatr Dermatol. 2001;18(6):504–6.

    Article  CAS  PubMed  Google Scholar 

  36. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy. N Engl J Med. 1990;322(20):1412–9.

    Article  CAS  PubMed  Google Scholar 

  37. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A. 1992;89(11):5152–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Lumbroso S, Paris F, Sultan C. McCune-Albright syndrome: molecular genetics. J Pediatr Endocrinol Metab. 2002;15 Suppl 3:875–82.

    CAS  PubMed  Google Scholar 

  39. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688–95.

    Article  CAS  PubMed  Google Scholar 

  40. Kim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, Yeo UC, Song SM, Kim JS, Uhm MR, Beck NS, Jin DK. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res. 1999;52(5):235–40.

    CAS  PubMed  Google Scholar 

  41. Weinstein LS. G(s)alpha mutations in fibrous dysplasia and McCune-Albright syndrome. J Bone Miner Res. 2006;21 Suppl 2:120–4.

    Article  Google Scholar 

  42. Levine MA. Clinical implications of genetic defects in G proteins: oncogenic mutations in G alpha s as the molecular basis for the McCune-Albright syndrome. Arch Med Res. 1999;30(6):522–31.

    Article  CAS  PubMed  Google Scholar 

  43. Kitagawa S, Townsend BL, Hebert AA. Peutz-Jeghers syndrome. Dermatol Clin. 1995;13(1):127–33.

    CAS  PubMed  Google Scholar 

  44. Patel LM, Lambert PJ, Gagna CE, Maghari A, Lambert WC. Cutaneous signs of systemic disease. Clin Dermatol. 2011;29(5):511–22.

    Article  PubMed  Google Scholar 

  45. McKenna KE, Walsh MY, Burrows D. Pigmentation of Peutz-Jeghers syndrome occurring in psoriatic plaques. Dermatology. 1994;189(3):297–300.

    Article  CAS  PubMed  Google Scholar 

  46. Shivaswamy KN, Shyamprasad AL, Sumathy TK, Ranganathan C. Peutz-Jeghers syndrome with prominent palmoplantar pigmentation. Indian J Dermatol Venereol Leprol. 2008;74(2):154–5.

    Article  CAS  PubMed  Google Scholar 

  47. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391(6663):184–7.

    Article  CAS  PubMed  Google Scholar 

  48. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  49. Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S, Bertario L, Blanco I, Bulow S, Burn J, Capella G, Colas C, Friedl W, Moller P, Hes FJ, Jarvinen H, Mecklin JP, Nagengast FM, Parc Y, Phillips RK, Hyer W, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Tejpar S, Thomas HJ, Wijnen JT, Clark SK, Hodgson SV. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975–86.

    Article  CAS  PubMed  Google Scholar 

  50. Westerman AM, Entius MM, Boor PP, Koole R, de Baar E, Offerhaus GJ, Lubinski J, Lindhout D, Halley DJ, de Rooij FW, Wilson JH. Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat. 1999;13(6):476–81.

    Article  CAS  PubMed  Google Scholar 

  51. Carling D. LKB1: a sweet side to Peutz-Jeghers syndrome? Trends Mol Med. 2006;12(4):144–7.

    Article  CAS  PubMed  Google Scholar 

  52. Boudeau J, Sapkota G, Alessi DR. LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett. 2003;546(1):159–65.

    Article  CAS  PubMed  Google Scholar 

  53. Forcet C, Etienne-Manneville S, Gaude H, Fournier L, Debilly S, Salmi M, Baas A, Olschwang S, Clevers H, Billaud M. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. Hum Mol Genet. 2005;14(10):1283–92.

    Article  CAS  PubMed  Google Scholar 

  54. Lin-Marq N, Borel C, Antonarakis SE. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Mol Genet Genomics. 2005;273(2):184–96.

    Article  CAS  PubMed  Google Scholar 

  55. Karuman P, Gozani O, Odze RD, Zhou XC, Zhu H, Shaw R, Brien TP, Bozzuto CD, Ooi D, Cantley LC, Yuan J. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell. 2001;7(6):1307–19.

    Article  CAS  PubMed  Google Scholar 

  56. Cordova A. The Mongolian spot: a study of ethnic differences and a literature review. Clin Pediatr (Phila). 1981;20(11):714–9.

    Article  CAS  Google Scholar 

  57. Vélez A, Fuente C, Belinchón I, Martín N, Furió V, Sánchez Yus E. Congenital segmental dermal melanocytosis in an adult. Arch Dermatol. 1992;128(4):521–5.

    Article  PubMed  Google Scholar 

  58. Zembowicz A, Mihm MC. Dermal dendritic melanocytic proliferations: an update. Histopathology. 2004;45(5):433–51.

    Article  CAS  PubMed  Google Scholar 

  59. Gupta D, Thappa DM. Mongolian spots: how important are they? World J Clin Cases. 2013;1(8):230–2.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Hanson M, Lupski JR, Hicks J, Metry D. Association of dermal melanocytosis with lysosomal storage disease: clinical features and hypotheses regarding pathogenesis. Arch Dermatol. 2003;139(7):916–20.

    Article  PubMed  Google Scholar 

  61. Leung AK, Robson WL. Mongolian spots and GM1 gangliosidosis type one. J R Soc Med. 1993;86(2):120–1.

    CAS  Google Scholar 

  62. Ochiai T, Ito K, Okada T, Chin M, Shichino H, Mugishima H. Significance of extensive Mongolian spots in Hunter’s syndrome. Br J Dermatol. 2003;148(6):1173–8.

    Article  CAS  PubMed  Google Scholar 

  63. Silengo M, Battistoni G, Spada M. Is there a relationship between extensive mongolian spots and inborn errors of metabolism? Am J Med Genet. 1999;87(3):276–7.

    Article  CAS  PubMed  Google Scholar 

  64. Wolf R, Wolf D, Davidovici B. Phacomatosis pigmentopigmentalis: aberrant Mongolian spots and segmental cafe au lait macules. Pediatr Dermatol. 2009;26(2):228–9.

    Article  PubMed  Google Scholar 

  65. Schaffer JV, Orlow SJ, Lazova R, Bolognia JL. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol. 2001;137(2):172–8.

    CAS  PubMed  Google Scholar 

  66. Falo Jr LD, Sober AJ, Barnhill RL. Evolution of a naevus spilus. Dermatology. 1994;189(4):382–3.

    Article  PubMed  Google Scholar 

  67. Vaidya DC, Schwartz RA, Janniger CK. Nevus spilus. Cutis. 2007;80(6):465–8.

    PubMed  Google Scholar 

  68. Happle R. Speckled lentiginous naevus: which of the two disorders do you mean? Clin Exp Dermatol. 2009;34(2):133–5.

    Article  CAS  PubMed  Google Scholar 

  69. Stewart DM, Altman J, Mehregan AH. Speckled lentiginous nevus. Arch Dermatol. 1978;114(6):895–6.

    Article  CAS  PubMed  Google Scholar 

  70. Hwang SM, Choi EH, Lee WS, Choi SI, Ahn SK. Nevus spilus (speckled lentiginous nevus) associated with a nodular neurotized nevus. Am J Dermatopathol. 1997;19(3):308–11.

    Article  CAS  PubMed  Google Scholar 

  71. Altman DA, Banse L. Zosteriform speckled lentiginous nevus. J Am Acad Dermatol. 1992;27(1):106–8.

    Article  CAS  PubMed  Google Scholar 

  72. Mishima Y, Mevorah B. Nevus Ota and nevus Ito in American Negroes. J Invest Dermatol. 1961;36:133–54.

    Article  CAS  PubMed  Google Scholar 

  73. Mataix J, Lopez N, Haro R, Gonzalez E, Angulo J, Requena L. Late-onset Ito’s nevus: an uncommon acquired dermal melanocytosis. J Cutan Pathol. 2007;34(8):640–3.

    Article  PubMed  Google Scholar 

  74. Resende C, Araujo C, Vieira AP, Brito C. Late onset Ito’s nevus. BMJ Case Rep. 2013. doi:10.1136/bcr-2013-009746.

    Google Scholar 

  75. Haim T, Meyer E, Kerner H, Zonis S. Oculodermal melanocytosis (nevus of Ota) and orbital malignant melanoma. Ann Ophthalmol. 1982;14(12):1132–6.

    CAS  PubMed  Google Scholar 

  76. Hirayama T, Suzuki T. A new classification of Ota’s nevus based on histopathological features. Dermatologica. 1991;183(3):169–72.

    Article  CAS  PubMed  Google Scholar 

  77. Sinha S, Cohen PJ, Schwartz RA. Nevus of Ota in children. Cutis. 2008;82(1):25–9.

    PubMed  Google Scholar 

  78. Hino K, Nagane M, Fujioka Y and Shiokawa Y. Meningeal melanocytoma associated with ipsilateral nevus of Ota presenting as intracerebral hemorrhage: case report. Neurosurgery 2005;56(6): E1376; discussion E1376

    Google Scholar 

  79. Patel BC, Egan CA, Lucius RW, Gerwels JW, Mamalis N, Anderson RL. Cutaneous malignant melanoma and oculodermal melanocytosis (nevus of Ota): report of a case and review of the literature. J Am Acad Dermatol. 1998;38(5 Pt 2):862–5.

    Article  CAS  PubMed  Google Scholar 

  80. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O’Brien JM, Simpson EM, Barsh GS, Bastian BC. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.

    Article  PubMed  CAS  Google Scholar 

  81. Goss BD, Forman D, Ansell PE, Bennett V, Swerdlow AJ, Burge S, Ryan TJ. The prevalence and characteristics of congenital pigmented lesions in newborn babies in Oxford. Paediatr Perinat Epidemiol. 1990;4(4):448–57.

    Article  CAS  PubMed  Google Scholar 

  82. Castilla EE, da Graca Dutra M, Orioli-Parreiras IM. Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol. 1981;104(3):307–15.

    Article  CAS  PubMed  Google Scholar 

  83. Zayour M, Lazova R. Congenital melanocytic nevi. Clin Lab Med. 2011;31(2):267–80.

    Article  PubMed  Google Scholar 

  84. Lu D, Levin EC, Dehner LP, Lind AC. Proliferative activity in melanocytic nevi from patients grouped by age with clinical follow-up. J Cutan Pathol. 2015;42(12):959–64.

    Article  Google Scholar 

  85. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, Wasti Q, Kopf AW, Bart RS. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol. 1997;36(3 Pt 1):409–16.

    Article  CAS  PubMed  Google Scholar 

  86. van Houten AH, van Dijk MCRF, Schuttelaar M-LA. Proliferative nodules in a giant congenital melanocytic nevus-case report and review of the literature. J Cutan Pathol. 2010;37(7):764–76.

    Article  PubMed  Google Scholar 

  87. Xu X, Bellucci KSW, Elenitsas R, Elder DE. Cellular nodules in congenital pattern nevi. J Cutan Pathol. 2004;31(2):153–9.

    Article  PubMed  Google Scholar 

  88. Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179–82.

    Article  CAS  PubMed  Google Scholar 

  89. Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126(9):2111–8.

    Article  CAS  PubMed  Google Scholar 

  90. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33(1):19–20.

    Article  CAS  PubMed  Google Scholar 

  91. Yazdi AS, Palmedo G, Flaig MJ, Puchta U, Reckwerth A, Rutten A, Mentzel T, Hugel H, Hantschke M, Schmid-Wendtner MH, Kutzner H, Sander CA. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol. 2003;121(5):1160–2.

    Article  CAS  PubMed  Google Scholar 

  92. McGill GG, Haq R, Nishimura EK, Fisher DE. c-Met expression is regulated by Mitf in the melanocyte lineage. J Biol Chem. 2006;281(15):10365–73.

    Article  CAS  PubMed  Google Scholar 

  93. Yoshida H, Kunisada T, Grimm T, Nishimura EK, Nishioka E, Nishikawa SI. Review: melanocyte migration and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc. 2001;6(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  94. Takayama H, La Rochelle WJ, Anver M, Bockman DE, Merlino G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A. 1996;93(12):5866–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A. 1997;94(2):701–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Luo R, Gao J, Wehrle-Haller B, Henion PD. Molecular identification of distinct neurogenic and melanogenic neural crest sublineages. Development. 2003;130(2):321–30.

    Article  CAS  PubMed  Google Scholar 

  97. Herron MD, Vanderhooft SL, Smock K, Zhou H, Leachman SA, Coffin C. Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis. Am J Surg Pathol. 2004;28(8):1017–25.

    Article  PubMed  Google Scholar 

  98. Dal Pozzo V, Benelli C, Restano L, Gianotti R, Cesana BM. Clinical review of 247 case records of Spitz nevus (epithelioid cell and/or spindle cell nevus). Dermatology. 1997;194(1):20–5.

    Article  CAS  PubMed  Google Scholar 

  99. Paniago-Pereira C, Maize JC, Ackerman AB. Nevus of large spindle and/or epithelioid cells (Spitz’s nevus). Arch Dermatol. 1978;114(12):1811–23.

    Article  CAS  PubMed  Google Scholar 

  100. Bandino JP, Kazlouskaya V, Ergin S, Moles-Poveda P, Cleaver NJ, Kabigting FD, Shackelton JB, Thieu K, Elston DM. Epidermal consumption in benign and malignant melanocytic neoplasms. J Cutan Pathol. 2015;42(12):937–43.

    Article  Google Scholar 

  101. Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions part I. Background and diagnoses. J Am Acad Dermatol. 2011;65(6):1073–84.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Harvell JD, Meehan SA, LeBoit PE. Spitz’s nevi with halo reaction: a histopathologic study of 17 cases. J Cutan Pathol. 1997;24(10):611–9.

    Article  CAS  PubMed  Google Scholar 

  103. Howat AJ, Variend S. Lymphatic invasion in Spitz nevi. Am J Surg Pathol. 1985;9(2):125–8.

    Article  CAS  PubMed  Google Scholar 

  104. Busam KJ, Barnhill RL. Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol. 1995;19(9):1061–7.

    Article  CAS  PubMed  Google Scholar 

  105. Peters MS, Goellner JR. Spitz naevi and malignant melanomas of childhood and adolescence. Histopathology. 1986;10(12):1289–302.

    Article  CAS  PubMed  Google Scholar 

  106. Requena C, Botella R, Nagore E, Sanmartín O, Llombart B, Serra-Guillén C, Guillén C, Requena L, Traves V. Characteristics of spitzoid melanoma and clues for differential diagnosis with spitz nevus. Am J Dermatopathol. 2012;34(5):478–86.

    Article  PubMed  Google Scholar 

  107. Walsh N, Crotty K, Palmer A, McCarthy S. Spitz nevus versus spitzoid malignant melanoma: an evaluation of the current distinguishing histopathologic criteria. Hum Pathol. 1998;29(10):1105–12.

    Article  CAS  PubMed  Google Scholar 

  108. Spatz A, Calonje E, Handfield-Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol. 1999;135(3):282–5.

    Article  CAS  PubMed  Google Scholar 

  109. Dika E, Fanti PA, Fiorentino M, Capizzi E, Neri I, Piraccini BM, Ravaioli GM, Misciali C, Passarini B, Patrizi A. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis. Melanoma Res. 2015;25(4):295–301.

    Article  PubMed  Google Scholar 

  110. Massi D, Tomasini C, Senetta R, Paglierani M, Salvianti F, Errico ME, Donofrio V, Collini P, Tragni G, Sementa AR, Rongioletti F, Boldrini R, Ferrari A, Gambini C, Montesco MC. Atypical Spitz tumors in patients younger than 18 years. J Am Acad Dermatol. 2015;72(1):37–46.

    Article  PubMed  Google Scholar 

  111. Mills OL, Marzban S, Zager JS, Sondak VK, Messina JL. Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients. J Cutan Pathol. 2012;39(3):331–6.

    Article  PubMed  Google Scholar 

  112. Smith KJ, Barrett TL, Skelton 3rd HG, Lupton GP, Graham JH. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13(11):931–9.

    Article  CAS  PubMed  Google Scholar 

  113. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Busam KJ. Molecular pathology of melanocytic tumors. Semin Diagn Pathol. 2013;30(4):362–74.

    Article  PubMed  Google Scholar 

  115. Da Forno PD, Pringle JH, Fletcher A, Bamford M, Su L, Potter L, Saldanha G. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Br J Dermatol. 2009;161(2):364–72.

    Article  PubMed  CAS  Google Scholar 

  116. Gill M, Renwick N, Silvers DN, Celebi JT. Lack of BRAF mutations in Spitz nevi. J Invest Dermatol. 2004;122(5):1325–6.

    Article  PubMed  Google Scholar 

  117. Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Komminoth P, Heitz PU. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma. Anticancer Res. 2004;24(4):2415–8.

    CAS  PubMed  Google Scholar 

  118. Palmedo G, Hantschke M, Rutten A, Mentzel T, Hugel H, Flaig MJ, Yazdi AS, Sander CA, Kutzner H. The T1796A mutation of the BRAF gene is absent in Spitz nevi. J Cutan Pathol. 2004;31(3):266–70.

    Article  PubMed  Google Scholar 

  119. Fullen DR, Poynter JN, Lowe L, Su LD, Elder JT, Nair RP, Johnson TM, Gruber SB. BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol. 2006;19(10):1324–32.

    Article  CAS  PubMed  Google Scholar 

  120. La Porta CA, Cardano R, Facchetti F, Presicce P, Rao S, Privitera E, Clemente C, Mihm Jr MC. BRAF V599E mutation occurs in Spitz and Reed naevi. J Eur Acad Dermatol Venereol. 2006;20(9):1164–5.

    Article  PubMed  Google Scholar 

  121. Maldonado JL, Timmerman L, Fridlyand J, Bastian BC. Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol. 2004;164(5):1783–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  122. Al Dhaybi R, Agoumi M, Gagne I, McCuaig C, Powell J, Kokta V. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi. J Am Acad Dermatol. 2011;65(2):357–63.

    Article  CAS  PubMed  Google Scholar 

  123. Hilliard NJ, Krahl D, Sellheyer K. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol. 2009;36(7):753–9.

    Article  PubMed  Google Scholar 

  124. Yoradjian A, Enokihara MM, Paschoal FM. Spitz nevus and Reed nevus. An Bras Dermatol. 2012;87(3):349–57. quiz 358–349.

    Article  PubMed  Google Scholar 

  125. Ferrara G, Argenziano G, Soyer HP, Chimenti S, Di Blasi A, Pellacani G, Peris K, Piccolo D, Rubegni P, Seidenari S, Staibano S, Zalaudek I, De Rosa G. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol. 2005;141(11):1381–7.

    Article  PubMed  Google Scholar 

  126. Sau P, Graham JH, Helwig EB. Pigmented spindle cell nevus: A clinicopathologic analysis of ninety-five cases. J Am Acad Dermatol. 1993;28(4):565–71.

    Article  CAS  PubMed  Google Scholar 

  127. Requena L, Sanchez Yus E. Pigmented spindle cell naevus. Br J Dermatol. 1990;123(6):757–63.

    Article  CAS  PubMed  Google Scholar 

  128. Smith NP. The pigmented spindle cell tumor of Reed: an underdiagnosed lesion. Semin Diagn Pathol. 1987;4(1):75–87.

    CAS  PubMed  Google Scholar 

  129. Barnhill RL, Barnhill MA, Berwick M, Mihm Jr MC. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol. 1991;22(1):52–8.

    Article  CAS  PubMed  Google Scholar 

  130. Diaz A, Valera A, Carrera C, Hakim S, Aguilera P, Garcia A, Palou J, Puig S, Malvehy J, Alos L. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies. Am J Surg Pathol. 2011;35(11):1733–42.

    Article  PubMed  Google Scholar 

  131. Kang S, Barnhill RL, Mihm Jr MC, Fitzpatrick TB, Sober AJ. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol. 1994;130(8):999–1001.

    Article  CAS  PubMed  Google Scholar 

  132. Akyol M, Atli AG, Ozcelik S, Cinar Z, Cig FA, Bircan H. Prevalence of common and atypical melanocytic nevi in Turkish children. Eur J Dermatol. 2008;18(4):422–6.

    PubMed  Google Scholar 

  133. Roth ME, Grant-Kels JM. Important melanocytic lesions in childhood and adolescence. Pediatr Clin North Am. 1991;38(4):791–809.

    Article  CAS  PubMed  Google Scholar 

  134. Haley JC, Hood AF, Chuang TY, Rasmussen J. The frequency of histologically dysplastic nevi in 199 pediatric patients. Pediatr Dermatol. 2000;17(4):266–9.

    Article  CAS  PubMed  Google Scholar 

  135. Novakovic B, Clark Jr WH, Fears TR, Fraser MC, Tucker MA. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol. 1995;33(4):631–6.

    Article  CAS  PubMed  Google Scholar 

  136. Fernandez M, Raimer SS, Sánchez RL. Dysplastic nevi of the scalp and forehead in children. Pediatr Dermatol. 2001;18(1):5–8.

    Article  CAS  PubMed  Google Scholar 

  137. Magro CM, Yaniv S, Mihm MC. The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: a distinct form of dysplastic Spitzoid nevomelanocytic proliferation. J Am Acad Dermatol. 2009;60(5):814–23.

    Article  PubMed  Google Scholar 

  138. Toussaint S, Kamino H. Dysplastic changes in different types of melanocytic nevi. A unifying concept. J Cutan Pathol. 1999;26(2):84–90.

    Article  CAS  PubMed  Google Scholar 

  139. Robinson WA, Lemon M, Elefanty A, Harrison-Smith M, Markham N, Norris D. Human acquired naevi are clonal. Melanoma Res. 1998;8(6):499–503.

    Article  CAS  PubMed  Google Scholar 

  140. Hussein MR, Wood GS. Molecular aspects of melanocytic dysplastic nevi. J Mol Diagn. 2002;4(2):71–80.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA, Marais R, Wynford-Thomas D, Bennett DC. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer. 2006;95(4):496–505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Duffy K and Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol 2012;67(1): 19 e11-12; quiz 31–12

    Google Scholar 

  143. Papp T, Pemsel H, Rollwitz I, Schipper H, Weiss DG, Schiffmann D, Zimmermann R. Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi. J Med Genet. 2003;40(2):E14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  144. Wang H, Presland RB, Piepkorn M. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection. Arch Dermatol. 2005;141(2):177–80.

    Article  CAS  PubMed  Google Scholar 

  145. Uribe P, Andrade L, Gonzalez S. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. J Invest Dermatol. 2006;126(1):161–6.

    Article  CAS  PubMed  Google Scholar 

  146. Wu J, Rosenbaum E, Begum S, Westra WH. Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol. 2007;29(6):534–7.

    Article  PubMed  Google Scholar 

  147. Luzar B, Calonje E. Deep penetrating nevus: a review. Arch Pathol Lab Med. 2011;135(3):321–6.

    PubMed  Google Scholar 

  148. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol. 2009;16(6):365–82.

    Article  PubMed  Google Scholar 

  149. Seab Jr JA, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol. 1989;13(1):39–44.

    Article  PubMed  Google Scholar 

  150. Mehregan DA, Mehregan AH. Deep penetrating nevus. Arch Dermatol. 1993;129(3):328–31.

    Article  CAS  PubMed  Google Scholar 

  151. Robson A, Morley-Quante M, Hempel H, McKee PH, Calonje E. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology. 2003;43(6):529–37.

    Article  CAS  PubMed  Google Scholar 

  152. Cooper PH. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J Cutan Pathol. 1992;19(3):172–80.

    Article  CAS  PubMed  Google Scholar 

  153. Ridha H, Ahmed S, Theaker JM, Horlock N. Malignant melanoma and deep penetrating naevus--difficulties in diagnosis in children. J Plast Reconstr Aesthet Surg. 2007;60(11):1252–5.

    Article  PubMed  Google Scholar 

  154. Bender RP, McGinniss MJ, Esmay P, Velazquez EF, Reimann JD. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Mod Pathol. 2013;26(10):1320–8.

    Article  CAS  PubMed  Google Scholar 

  155. Roesch A, Becker B, Bentink S, Spang R, Vogl A, Hagen I, Landthaler M, Vogt T. Ataxia telangiectasia-mutated gene is a possible biomarker for discrimination of infiltrative deep penetrating nevi and metastatic vertical growth phase melanoma. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2486–90.

    Article  CAS  PubMed  Google Scholar 

  156. Mason AR, Mohr MR, Koch LH, Hood AF. Nevi of special sites. Clin Lab Med. 2011;31(2):229–42.

    Article  PubMed  Google Scholar 

  157. Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol 2006;19(Suppl 2): S4-20

    Google Scholar 

  158. Evans MJ, Gray ES, Blessing K. Histopathological features of acral melanocytic nevi in children: study of 21 cases. Pediatr Dev Pathol. 1998;1(5):388–92.

    Article  CAS  PubMed  Google Scholar 

  159. Cheung WL, Smoller BR. Dermatopathology updates on melanocytic lesions. Dermatol Clin. 2012;30(4):617–22. vi.

    Article  CAS  PubMed  Google Scholar 

  160. Gleason BC, Hirsch MS, Nucci MR, Schmidt BA, Zembowicz A, Mihm Jr MC, McKee PH, Brenn T. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32(1):51–7.

    Article  PubMed  Google Scholar 

  161. Hosler GA, Moresi JM, Barrett TL. Nevi with site-related atypia: a review of melanocytic nevi with atypical histologic features based on anatomic site. J Cutan Pathol. 2008;35(10):889–98.

    Article  PubMed  Google Scholar 

  162. Fabrizi G, Pagliarello C, Parente P, Massi G. Atypical nevi of the scalp in adolescents. J Cutan Pathol. 2007;34(5):365–9.

    Article  PubMed  Google Scholar 

  163. Patrizi A, Bentivogli M, Raone B, Dondi A, Tabanelli M, Neri I. Association of halo nevus/i and vitiligo in childhood: a retrospective observational study. J Eur Acad Dermatol Venereol. 2013;27(2):e148–52.

    Article  CAS  PubMed  Google Scholar 

  164. Langer K, Konrad K. Congenital melanocytic nevi with halo phenomenon: report of two cases and a review of the literature. J Dermatol Surg Oncol. 1990;16(4):377–80.

    Article  CAS  PubMed  Google Scholar 

  165. Aouthmany M, Weinstein M, Zirwas MJ, Brodell RT. The natural history of halo nevi: a retrospective case series. J Am Acad Dermatol. 2012;67(4):582–6.

    Article  PubMed  Google Scholar 

  166. Patrizi A, Neri I, Sabattini E, Rizzoli L, Misciali C. Unusual inflammatory and hyperkeratotic halo naevus in children. Br J Dermatol. 2005;152(2):357–60.

    Article  CAS  PubMed  Google Scholar 

  167. Stierman SC, Tierney EP, Shwayder TA. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature. Pediatr Dermatol. 2009;26(4):414–24.

    Article  PubMed  Google Scholar 

  168. Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol. 1997;37(4):620–4.

    Article  CAS  PubMed  Google Scholar 

  169. Vera-Iglesias E, Garcia-Arpa M, Sanchez-Caminero P. Halo nevi associated with interferon beta-1a therapy. Actas Dermosifiliogr. 2012;103(1):75–6.

    Article  Google Scholar 

  170. Barros JA, Kafler CC, Barros JC, Proto RS, Priscila dos Santos C, Machado Filho CD. Comparative dermatology: blue nevus. An Bras Dermatol. 2012;87(4):661–2.

    Article  PubMed  Google Scholar 

  171. Kamino H, Tam ST. Compound blue nevus: a variant of blue nevus with an additional junctional dendritic component. A clinical, histopathologic, and immunohistochemical study of six cases. Arch Dermatol. 1990;126(10):1330–3.

    Article  CAS  PubMed  Google Scholar 

  172. Pulitzer DR, Martin PC, Cohen AP, Reed RJ. Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi. Am J Surg Pathol. 1991;15(12):1111–22.

    Article  CAS  PubMed  Google Scholar 

  173. Busam KJ. Metastatic melanoma to the skin simulating blue nevus. Am J Surg Pathol. 1999;23(3):276–82.

    Article  CAS  PubMed  Google Scholar 

  174. Emley A, Nguyen LP, Yang S, Mahalingam M. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi. Hum Pathol. 2010;42(1):136–40.

    Article  PubMed  CAS  Google Scholar 

  175. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O’Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010;363(23):2191–9.

    Article  PubMed  PubMed Central  Google Scholar 

  176. Van Raamsdonk CD, Fitch KR, Fuchs H, de Angelis MH, Barsh GS. Effects of G-protein mutations on skin color. Nat Genet. 2004;36(9):961–8.

    Article  PubMed  CAS  Google Scholar 

  177. Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med. 2011;135(3):327–36.

    PubMed  Google Scholar 

  178. Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol. 1975;111(12):1588–90.

    Article  CAS  PubMed  Google Scholar 

  179. Haupt HM, Stern JB. Pagetoid melanocytosis. Histologic features in benign and malignant lesions. Am J Surg Pathol. 1995;19(7):792–7.

    Article  CAS  PubMed  Google Scholar 

  180. Fox JC, Reed JA, Shea CR. The recurrent nevus phenomenon: a history of challenge, controversy, and discovery. Arch Pathol Lab Med. 2011;135(7):842–6.

    PubMed  Google Scholar 

  181. Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001;28(8):400–6.

    Article  CAS  PubMed  Google Scholar 

  182. King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm Jr MC. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol. 2009;22(5):611–7.

    Article  CAS  PubMed  Google Scholar 

  183. Nishimura EK, Jordan SA, Oshima H, Yoshida H, Osawa M, Moriyama M, Jackson IJ, Barrandon Y, Miyachi Y, Nishikawa S. Dominant role of the niche in melanocyte stem-cell fate determination. Nature. 2002;416(6883):854–60.

    Article  CAS  PubMed  Google Scholar 

  184. Arrese Estrada J, Pierard-Franchimont C, Pierard GE. Histogenesis of recurrent nevus. Am J Dermatopathol. 1990;12(4):370–2.

    Article  CAS  PubMed  Google Scholar 

  185. Hadley C, Mohila CA, Luerssen TG, Lam S. Congenital neurocristic tumor presenting as an isolated calvarial defect in an infant: case report. J Neurosurg Pediatr. 2015;16(1):46–9.

    Article  PubMed  Google Scholar 

  186. Mezebish D, Smith K, Williams J, Menon P, Crittenden J, Skelton H. Neurocristic cutaneous hamartoma: a distinctive dermal melanocytosis with an unknown malignant potential. Mod Pathol. 1998;11(6):573–8.

    CAS  PubMed  Google Scholar 

  187. Karamitopoulou-Diamantis E, Paredes B, Vajtai I. Cutaneous neurocristic hamartoma with blue naevus-like features and plexiform dermal hyperneury. Histopathology. 2006;49(3):326–8.

    Article  CAS  PubMed  Google Scholar 

  188. Smith KJ, Mezebish D, Williams J, Elgart ML, Skelton HG. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol. 1998;2(4):213–23.

    Article  CAS  PubMed  Google Scholar 

  189. Pearson JP, Weiss SW, Headington JT. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas. A melanocytic tumor morphologically and biologically distinct from common melanoma. Am J Surg Pathol. 1996;20(6):665–77.

    Article  CAS  PubMed  Google Scholar 

  190. Turel MK, Chacko G, Raja A, Scheithauer BW. Neurocristic cutaneous hamartoma of the scalp. J Pediatr Neurosci. 2012;7(3):181–4.

    Article  PubMed  PubMed Central  Google Scholar 

  191. Saha D, Kini UA, Kini H. Cutaneous neurocristic hamartoma presenting as cutis verticis gyrata. Am J Dermatopathol. 2014;36(3):e66–9.

    Article  PubMed  Google Scholar 

  192. Reed RJ. Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme. Am J Dermatopathol. 1983;5(4):385–95.

    Article  CAS  PubMed  Google Scholar 

  193. Kamino H. Spitzoid melanoma. Clin Dermatol. 2009;27(6):545–55.

    Article  PubMed  Google Scholar 

  194. Paradela S, Fonseca E, Pita S, Kantrow SM, Goncharuk VN, Diwan H, Prieto VG. Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol. 2009;36(7):740–52.

    Article  PubMed  Google Scholar 

  195. Ferrara G, Gianotti R, Cavicchini S, Salviato T, Zalaudek I, Argenziano G. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. Dermatol Clin. 2013;31(4):589–98. viii.

    Article  CAS  PubMed  Google Scholar 

  196. Zedek DC, McCalmont TH. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma. Clin Lab Med. 2011;31(2):311–20.

    Article  PubMed  Google Scholar 

  197. Crotty KA, Scolyer RA, Li L, Palmer AA, Wang L, McCarthy SW. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology. 2002;34(1):6–12.

    Article  PubMed  Google Scholar 

  198. Wiesner T, He J, Yelensky R, Esteve-Puig R, Botton T, Yeh I, Lipson D, Otto G, Brennan K, Murali R, Garrido M, Miller VA, Ross JS, Berger MF, Sparatta A, Palmedo G, Cerroni L, Busam KJ, Kutzner H, Cronin MT, Stephens PJ, Bastian BC. Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun. 2014;5:3116.

    PubMed  PubMed Central  Google Scholar 

  199. Gill M, Cohen J, Renwick N, Mones JM, Silvers DN, Celebi JT. Genetic similarities between Spitz nevus and Spitzoid melanoma in children. Cancer. 2004;101(11):2636–40.

    Article  PubMed  Google Scholar 

  200. Da Forno PD, Fletcher A, Pringle JH, Saldanha GS. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol. 2008;158(1):4–14.

    PubMed  Google Scholar 

  201. Lee DA, Cohen JA, Twaddell WS, Palacios G, Gill M, Levit E, Halperin AJ, Mones J, Busam KJ, Silvers DN, Celebi JT. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer. 2006;106(4):907–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology & Immunology, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas, USA

    Thuy L. Phung MD, PhD

  2. Departments of Dermatology and Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA

    Teresa S. Wright MD

  3. Departments of Dermatology and Pediatrics, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas, USA

    Crystal Y. Pourciau MD, MPH

  4. Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

    Bruce R. Smoller MD

Authors
  1. Thuy L. Phung MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teresa S. Wright MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Crystal Y. Pourciau MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruce R. Smoller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Phung, T.L., Wright, T.S., Pourciau, C.Y., Smoller, B.R. (2017). Melanocytic Proliferations and Other Pigmented Lesions. In: Pediatric Dermatopathology. Springer, Cham. https://doi.org/10.1007/978-3-319-44824-4_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44824-4_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44822-0

  • Online ISBN: 978-3-319-44824-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation